CS18: New Drug Shows Potential to Overcome Cancer Drug Resistance
Researchers at Baylor College of Medicine have developed an experimental anticancer compound that appears to make treatment-resistant tumors vulnerable again. ...
Researchers at Baylor College of Medicine have developed an experimental anticancer compound that appears to make treatment-resistant tumors vulnerable again. ...
The intricate architecture and dynamic nature of the tumor microenvironment (TME) present formidable challenges to the effective treatment of cancer. ...
In a groundbreaking advance toward precision oncology, researchers have unveiled a novel antibody-drug conjugate (ADC) specifically engineered to target anaplastic ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine